Diseases and Conditions
Approximately 80,000 women in the U.S. will be diagnosed with some type of gynecologic cancer this year. As with many cancers, screening and early detection are key factors and timely treatment can mean an excellent prognosis.
Our exceptional physicians, nurses and staff specializing in gynecologic oncology at the Montefiore-Einstein Center for Cancer Care are devoted to preventing, diagnosing and treating gynecologic cancers and have an active research program. We specialize in hormone-dependent cancers, including endometrial (uterine), cervical, ovarian, vulva and vaginal. Our state-of-the-art therapies include outpatient surgical techniques (LEEP, laser or cryotherapy), as well as laparoscopic surgery, precision radiation and chemotherapy.
Experts in Our Field
Studies suggest a higher rate of success when gynecologic cancers are treated by specialists in that field. Our staff includes five full-time, board-certified or board-eligible gynecologic oncologists, as well as specially trained clinicians, oncology nurses and support staff. Montefiore has one of only a few fellowship training programs in the nation in gynecologic oncology.
Multidisciplinary Coordinated Care
Our all-inclusive approach to care gives patients the benefit of our wide range of experience with skilled professionals spanning various disciplines. Each patient is assigned an oncology nurse who serves as her key contact—from diagnosis and treatment to coordinating social services, pain management, physical therapy and other necessary support.
Superior Screening, Diagnosis and Treatment
We offer outstanding diagnostics and screenings for all types of gynecologic cancer, excel at all aspects of diagnostic intervention and are constantly conducting research to further improve the field.
Advanced Capabilities for Ovarian Cancer
Particularly notable are our advanced capabilities for the screening and management of ovarian cancer. We offer a full genetic and clinical screening program that includes genetic counseling and testing. Those at risk may be candidates for preventive surgery or other interventions.
Upon diagnosis, Montefiore provides the latest cancer treatments available, including surgery, chemotherapy and radiation therapy. Working with our research partner Albert Einstein Cancer Center, a National Cancer Institute-designated Cancer Center, we offer state-of-the-art chemotherapy in our infusion units.
Research that Benefits Patients
Montefiore is a member of the prestigious Gynecology Oncology Group, a non-profit organization that promotes excellence in gynecologic oncology research and therapy. Our ongoing commitment to research is an outstanding benefit to our patients, who are often involved in therapeutic or investigational protocols run through the NCI and the National Institutes of Health.
Clinical Trials for HPV
Montefiore has been actively involved in a trial for the human papillomavirus (HPV), a sexually transmitted disease that has been associated with the development of cervical cancer. Our efforts are focused on patients with pre-malignant conditions of the cervix, offering them a vaccine against the virus. The second phase of our trial will include both treatment and prevention initiatives.
New Treatments for Cervical Cancer
Montefiore has long been a leading force in battling cervical cancer. Our patients were among the first nationwide to receive new treatment therapies that include coordinated chemotherapy and radiation therapy and high-dose-rate brachytherapy (HDR).